GRONINGEN, The Netherlands and MONTREAL, Nov. 28 /CNW/ - Kiadis B.V, a
Dutch early product development company, and Celmed BioSciences Inc., a
Canadian clinical product development company, today announce their plans to
merge both oncology-focused companies. The combined company will be named
Kiadis Pharma B.V. and headquartered in the Netherlands with supporting
facilities in the Netherlands and Canada.
